Trospium

Trospium

SCHEMBL31112961

O=C(OC1CC2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM2CHRM3

The experimentally established mechanism targets of Trospium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM3 known ✓ P20309 11/20 0.97
CHRM2 known ✓ P08172 10/20 0.97
CHRM1 P11229 4/20 0.97
KCNH2 Q12809 4/20 0.97
HRH1 P35367 3/20 0.97
CHRM4 P08173 1/20 0.95
CHRM5 P08912 1/20 0.95
OPRK1 P41145 1/20 0.61
SLC22A1 O15245 1/20 0.60
LMNA P02545 2/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 1/20 0.58
SLC6A4 P31645 1/20 0.58
RAB9A P51151 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trospium SCHEMBL724191 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL119810 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL2447242 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL13836646 0.97 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL22609933 0.97 CHRM3 (0.97) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL111738 0.97 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL25785 0.97 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL29389006 0.97 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL29629492 0.97 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL1707994 0.92 CHRM3 (0.89) CHRM3CHRM2CHRM1KCNH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
WO-2024226691-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. (US) 2024-10-31 WO disclosed